Working with corporate partners to support CSR goals and improve global cardio-kidney-metabolic health outcomes
At Beam, our mission is to improve the physical and mental health of all people with cardio-kidney-metabolic (CKM) conditions worldwide.
Our clinically-proven* digital platform, tailored specially to meet the needs of people with CKM conditions, can be easily deployed to support corporate social responsibility (CSR) initiatives aimed at improving outcomes for this complex and increasingly prevalent area of global health.
Developed in partnership with world-leading clinicians, charities and research institutions
Proven to improve health for people with CKM conditions
Beam is scientifically proven to improve physical function, mental health, ability to self-manage health, fatigue, and reduce social isolation
Backed by leading CKM researchers and clinicians
We are supported by world-leading CKM research organisations, universities and clinicians
Our virtual classes are 88% cheaper than face-to-face services
Virtual classes that can be delivered at scale, with comparable outcomes, far more affordably than face-to-face
*Greenwood et al, 2024, The Lancet Digital Health
Over a billion people worldwide have at least one of the main CKM conditions1.
Prevalence is rising rapidly as the population ages and risk factors increase, putting healthcare services under increasing strain - meaning innovative collaborations across public and private sectors are more needed than ever to meet the challenges presented.
Our cost-effective platform helps people with CKM conditions increase their physical activity and encourages better condition management, providing a wide range of tailored exercise and education content created by experts in CKM health.
We have several programmes available for corporate-backed health initiatives aimed at supporting this patient group - including digital rehabilitation, pre and post-transplant support, programmes for those on dialysis, living kidney donors, and for specific diagnoses such as polycystic kidney disease.
Helping the corporate sector make an impact on global health
Read our published evidence and case studies
As a clinically-led solution, we are proud to have several groundbreaking research studies published in multiple peer-reviewed journals, and also have a wide range of real-world implementation examples across different cardio-kidney-metabolic use cases.

Why should companies partner with Beam on health initiatives?
Evidence-based, clinically proven solution
Beam has been scientifically proven in a multi-centre randomised controlled clinical trial to significantly improve health outcomes for CKM patients compared to usual care
Support corporate social responsibility goals
Show commitment to corporate social responsibility initiatives and be at the forefront of supporting health innovation
Improve health outcomes for complex CKM patients
Proven to improve physical function, mental health, ability to self-manage, fatigue, and reduce social isolation
Safe, scalable, digitally-enabled access
Delivered via an easy-to-use digital app, increasing reach and user convenience
Backed by leading CKM charities, researchers and clinicians
We are supported by world-leading CKM charities, research organisations, universities and clinicians
£6 return-on-investment for every £1 spent
Proven to be a cost-effective solution in an independent health economic assessment
Feedback from clinicians and patients

Contact us to discuss providing Beam to support your CSR initiatives
We would love to discuss how Beam could help support the aims of your corporal social responsibility programme - please get in touch to find out more.